Biotechnology News and Research

RSS

SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of a peer-reviewed study in the International Wound Journal.

8 Jul 2025

Scientists uncover hidden superfamily of lipid trapping proteins in bacteria

Scientists have identified a new type of protein in bacteria that could change our understanding of how these organisms interact with their environments.

8 Jul 2025

Smallest known protein-based enzyme HARP reveals dual role in tRNA processing

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where they read the genetic instructions from messenger RNA, mRNA, and deliver the right amino acids to ribosomes, the cell's protein-making factories.

7 Jul 2025

Mediterranean bacteria show promise as new mosquito biopesticides

Mosquito-borne diseases kill more than 700,000 people every year, according to the World Health Organization, and the mosquitos that spread the disease are difficult to control.

7 Jul 2025

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding the field of synthetic biology and the potential of living diagnostics.

From Pittcon 7 Jul 2025

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers.

4 Jul 2025

New study moves closer to defeating dormant tuberculosis cells

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports.

4 Jul 2025

Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme.

2 Jul 2025

Experimental medication sensitizes glioblastoma to treatment and blocks tumor spread

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly sensitive to both radiation and chemotherapy drugs, and blocks the cancer's ability to invade other tissue, a new study shows.

2 Jul 2025

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing an improved approach to ranking virtual cell models for gene discovery.

1 Jul 2025

Beetle-inspired tuberculosis testing device offers accurate detection for people with HIV

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm.

27 Jun 2025

Global effort enters an active growth phase to preserve the Earth's microbial heritage

A global effort to create a "microbial Noah's Ark" to preserve the world's diverse collection of healthy microbes before they disappear is now entering an active growth phase.

27 Jun 2025

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical trial (NCT06414460) to evaluate ISM3412, a potentially best-in-class, AI-empowered MAT2A inhibitor with novel structure, in patients with locally advanced and metastatic solid tumors.

27 Jun 2025

LMU researchers uncover mechanism for metabolism without cell membranes

LMU researchers have demonstrated a possible mechanism for metabolic processes without cell membranes in water-filled pores.

27 Jun 2025

Deciphering the structure of human protease SENP5 unlocks new therapeutic paths

A research led by the IBB-UAB has managed to decypher the structure of the human protease SENP5, implicated in neurodegenerative disorders, cardiovascular diseases and the development of cancer.

27 Jun 2025

New study reveals how nymphaeol A interacts with cell membranes

A new study by Professor José Villalaín, Chair of Biochemistry and Molecular Biology at the Miguel Hernández University of Elche (UMH), provides a detailed description of how nymphaeol A - a compound found in propolis - behaves when interacting with cell membranes.

27 Jun 2025

Soil bacterium offers clues for new bioactive compounds

A recent study by an interdisciplinary research team shows how a soil bacterium can become a source of inspiration in the search of new active substances.

27 Jun 2025

Deadly central line-associated bloodstream infections could be prevented using new e-catheter hub

Washington State University and Mayo Clinic researchers have developed an electrochemical catheter hub that could someday help prevent deadly central line-associated bloodstream infections (CLABSIs) that annually kill thousands of people around the world.

25 Jun 2025

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.

25 Jun 2025

How a novel reaction in E. coli helps recycle plastic into paracetamol

Researchers have demonstrated that E. coli can perform a biocompatible Lossen rearrangement, enabling phosphate-catalysed conversion of synthetic substrates into valuable compounds. This approach allows engineered bacteria to upcycle PET plastic waste into paracetamol, highlighting a novel intersection of chemistry and biotechnology.

24 Jun 2025

Biotechnology News and Research

SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

Scientists uncover hidden superfamily of lipid trapping proteins in bacteria

Smallest known protein-based enzyme HARP reveals dual role in tRNA processing

Mediterranean bacteria show promise as new mosquito biopesticides

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

New study moves closer to defeating dormant tuberculosis cells

Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Experimental medication sensitizes glioblastoma to treatment and blocks tumor spread

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

Beetle-inspired tuberculosis testing device offers accurate detection for people with HIV

Global effort enters an active growth phase to preserve the Earth's microbial heritage

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

LMU researchers uncover mechanism for metabolism without cell membranes

Deciphering the structure of human protease SENP5 unlocks new therapeutic paths

New study reveals how nymphaeol A interacts with cell membranes

Soil bacterium offers clues for new bioactive compounds

Deadly central line-associated bloodstream infections could be prevented using new e-catheter hub

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

How a novel reaction in E. coli helps recycle plastic into paracetamol

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News